This content is provided by Chambers. Learn more about our methodology
What the team is known for Market-leading team frequently advising clients in the pharmaceutical and biotechnology sectors on transactional and regulatory matters. Also represents clients in contentious mandates, including patent-related litigation and vertical price fixing investigations. Acts for clients on capital fund raises and on licensing and distribution agreements. Further experience in the classification of medical devices.
Strengths One client remarks: "We find them very pragmatic - they really understand the real business requirements and approach the legal aspects with this in mind."
Sources also report that the team is "always contactable and reply quickly."
Work highlights Represented Eli Lilly in an investigation into alleged vertical price fixing.
Andri Hess boasts particular expertise in the patent field, advising international pharmaceutical and biotechnology companies on patent infringement and nullity proceedings.
Dieter Gericke advises on transactions within the life sciences field, as well as providing expertise in capital increases. One client underlines his "business-oriented" approach.